参考文献/References:
[1] Adler CH, Beach TG, Hentz JG, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease:Clinicopathologic study[J]. Neurology, 2014, 83(5):406-412. DOI:10. 1212/WNL. 0000000000000641.
[2] Holtbernd F, Eidelberg D. The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes[J]. Semin Neurol, 2014, 34(2):202-209. DOI:10. 1055/s-0034-1381733.
[3] Pagano G, Niccolini F, Politis M. Imaging in Parkinson’s disease[J]. Clin Med(Lond), 2016, 16(4):371-375. DOI:10.7861/clinmedicine. 16-4-371.
[4] Sarikaya I. PET imaging in neurology:Alzheimer’s and Parkinson’s diseases[J]. Nucl Med Commun, 2015, 36(8):775-781. DOI:10. 1097/mnm. 0000000000000320.
[5] Picco A, Morbelli S, Piccardo A, et al. Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease[J]. Eur J Nucl Med Mol Imaging, 2015, 42(7):1062-1070. DOI:10. 1007/s00259-015-3039-0.
[6] Otsuka M, Ichiya Y, Hosokawa S, et al. Striatal blood flow, glucose metabolism and 18F-dopa uptake:difference in Parkinson’s disease and atypical parkinsonism[J]. J Neurol Neurosurg Psychiatry, 1991, 54(10):898-904. DOI:10. 1136/jnnp. 54. 10. 898.
[7] Calabria FF, Calabria E, Gangemi V, et al. Current status and future challenges of brain imaging with 18F-DOPA PET for movement disorders[J]. Hell J Nucl Med, 2016, 19(1):33-41. DOI:10. 1967/s002449910335.
[8] Jaimini A, Tripathi M, D’Souza MM, et al. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson’s disease from atypical parkinsonian disorders[J]. Nucl Med Commun, 2013, 34(5):426-431. DOI:10. 1097/MNM. 0b013e32835fcd7f.
[9] Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of[I-123] -FP-CIT SPECT imaging:the[I-123] -FP-CIT study group[J]. Mov Disord, 2000, 15(3):503-510.
[10] Vlaar AM, van Kroonenburgh MJ, Kessels AG, et al. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes[J]. BMC Neurol, 2007, 7:27. DOI:10. 1186/1471-2377-7-27.
[11] Vlaar AM, de Nijs T, Kessels AG, et al. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes[J]. Eur Neurol, 2008, 59(5):258-266. DOI:10. 1159/000115640.
[12] Lorberboym M, Treves TA, Melamed E, et al.[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson’s disease[J]. Mov Disord, 2006, 21(4):510-514. DOI:10. 1002/mds. 20748.
[13] Messa C, Volonté MA, Fazio F, et al. Differential distribution of striatal[123I]beta-CIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography[J]. Eur J Nucl Med, 1998, 25(9):1270-1276. DOI:10. 1007/s002590050295.
[14] Plotkin M, Amthauer H, Klaffke S, et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes:study on 72 patients[J]. J Neural Transm(Vienna), 2005, 112(5):677-692. DOI:10. 1007/s00702-004-0208-x.
[15] Nocker M, Seppi K, Donnemiller E, et al. Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy:a voxel-based analysis of[123I]β-CIT SPECT[J]. Eur J Nucl Med Mol Imaging, 2012, 39(6):1012-1020. DOI:10. 1007/s00259-012-2100-5.
[16] Brigo F, Matinella A, Erro R, et al.[123I]FP-CIT SPECT(DaTSCAN) may be a useful tool to differentiate between Parkinson’s disease and vascular or drug-induced parkinsonisms:a meta-analysis[J]. Eur J Neurol, 2014, 21(11):1369-1390. DOI:10. 1111/ene. 12444.
[17] Van Laere K, Clerinx K, D’hondt E, et al. Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease[J]. J Nucl Med, 2010, 51(4):588-595. DOI:10. 2967/jnumed. 109. 070144.
[18] Tatsch K, Schwarz J, Oertel WH, et al. SPECT imaging of dopamine D2 receptors with 123I-IBZM:initial experience in controls and patients with Parkinson’s syndrome and Wilson’s disease[J]. Nucl Med Commun, 1991, 12(8):699-707. DOI:10. 1097/00006231-199108000-00005.
[19] Südmeyer M, Antke C, Zizek T, et al. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism:a multidimensional statistical approach[J]. J Nucl Med, 2011, 52(5):733-740. DOI:10. 2967/jnumed. 110. 086959.
[20] Hellwig S, Amtage F, Kreft A, et al.[18F]FDG-PET is superior to[125I]IBZM-SPECT for the differential diagnosis of parkinsonism[J]. Neurology, 2012, 79(13):1314-1322. DOI:10. 1212/WNL. 0b013e31826c1b0a.
[21] Koch W, Hamann C, Radau PE, et al. Does combined imaging of the pre-and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?[J]. Eur J Nucl Med Mol Imaging, 2007, 34(8):1265-1273. DOI:10. 1007/s00259-007-0375-8.
[22] Ishibashi K, Nishina H, Ishiwata K, et al. Individual time course of pre-and postsynaptic PET imaging may improve differential diagnosis of Parkinson’s disease and multiple system atrophy:a case report[J]. BMC Res Notes, 2015, 8:496. DOI:10. 1186/s13104-015-1522-0.
[23] Juh R, Kim J, Moon D, et al. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET[J]. Eur J Radiol, 2004, 51(3):223-233. DOI:10. 1016/S0720-048X(03)00214-6.
[24] Eidelberg D, Moeller JR, Ishikawa T, et al. Early differential diagnosis of Parkinson’s disease with 18F-fluorodeoxyglucose and positron emission tomography[J]. Neurology, 1995, 45(11):1995-2004. DOI:10. 1212/WNL. 45. 11. 1995.
[25] Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism:a metabolic imaging study using pattern analysis[J]. Lancet Neurol, 2010, 9(2):149-158. DOI:10. 1016/S1474-4422(10)70002-8.
[26] Tripathi M, Tang CC, Feigin A, et al. Automated differential diagnosis of early parkinsonism using metabolic brain networks:a validation study[J]. J Nucl Med, 2016, 57(1):60-66. DOI:10. 2967/jnumed. 115. 161992.
[27] Orimo S, Suzuki M, Inaba A, et al. 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism:a systematic review and meta-analysis[J]. Parkinsonism Relat Disord, 2012, 18(5):494-500. DOI:10. 1016/j. parkreldis. 2012. 01. 009.
[28] Rascol O, Schelosky L. 123I-metaiodobenzylguanidine scintigraphy in Parkinson’s disease and related disorders[J]. Mov Disord, 2009, Suppl 2:S732-741. DOI:10. 1002/mds. 22499.
[29] Nagayama H, Hamamoto M, Ueda M, et al. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease[J]. J Neurol Neurosurg Psychiatry, 2005, 76(2):249-251. DOI:10. 1136/jnnp. 2004. 037028.
相似文献/References:
[1]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[5]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[6]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[7]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[8]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[9]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[10]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]